Clinical updates, including trial initiations, enrollment status and data readouts and publications: Aslan, Astria, Atea, Biocryst, Codexis, Fulcrum, Innocare, Keymed, Merck, Nektar, Nestlé, Orchard, Oscotec, Prilenia, Regenxbio, Tvardi, Werewolf.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Feops, Sportgait.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: 4D Molecular, Accutar, Amicus, Astellas, Cantargia, Denali, Forge, Horizon, Janssen, Pharmaessentia, Regenxbio, Sangamo, Skye, Theratechnologies, Viiv.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Medtronic.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Alteogen, Biomx, Corium, Dare, Grid, Immunic, Immunocore, Jaguar, Kinnate, Linkinvax, Merck & Co., Modus, Shionogi.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Actinium, Aileron, Akari, Ascletis, BMS, Bridge, Effector, Gamida, Ionis, Junshi, Kinarus, Medivir, Merck & Co., Neurophth, Palvella, Pharming, Photocure, Scancell, Takeda, Telix, Westvac.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Ascletis, Boan, Coherus, Eluminex, Ena Respiratory, Immuno Cure, Immvira, Jiangsu Recbio Technology, Junshi, Scancell.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Glycomark, Masimo, Precision Diabetes.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Amniotics, Jasper, Merck, Moderna, NS, Orion, Pfizer, Sarepta, Theriva, Valneva.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Aldeyra, Alx, Ambrx, Applied Therapeutics, Ascletis, Aura, Bergenbio, Boan, Disc, Immuno Cure, Immvira, Innovent, Inovio, Inozyme, Pfizer.